MIRVASO In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Phase of Trial: Phase IV
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Brimonidine (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Acronyms MIRACLE
- Sponsors Galderma
- 10 Jun 2017 Biomarkers information updated
- 20 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2015 Planned End Date changed from 1 May 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.